Publications

Peer Reviewed Manuscripts:

  1. Kauffman, EC, Robinson, VL, Stadler, WM, Sokoloff, MH, Rinker-Schaeffer, CW.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.  Journal of Urology. 2003 Mar; 169(3):1122-1133.
  2. Robinson, VL, Kauffman, EC, Sokoloff, MH, Rinker-Schaeffer, CW.  Basic biology of metastasis.  Cancer Treatment and Research. 2004; 118: 1-21.
  3. Kauffman, EC, Raman, JD.  Upper urinary tract transitional cell carcinoma and subsequent bladder tumors. Expert Review of Anticancer Therapy. 2008 Jan; 8(1): 75-85.          
  4. Kauffman, EC, Barocas, DA, Chen, YT, Yang, XJ, Scherr, DS, Tu JJ.  The KAI1 metastasis suppressor protein is a novel marker for chromophobe renal cell carcinoma.  Journal of Urology.  2009 May; 181(5): 2305-11.               
  5. Kauffman EC, Kang HW, Choi BB.  The effect of laser-fiber sweeping speed on the efficiency of photoselective vaporization of the prostate in an ex vivo bovine model.  Journal of Endourology. 2009 Sep; 23(9): 1429-35.
  6. Ehrlich JR, Schwartz MJ, Ng CK, Kauffman EC, Scherr DS.  The impact of multiple malignancies on patients with bladder carcinoma: a population-based study using the SEER database. Advances in Urology. 2009  Dec.
  7. Ng CK, Kauffman EC, Lee MM, Otto BJ, Portnoff A, Ehrlich JR, Schwartz MJ, Wang GJ, Scherr DS. A comparison of postoperative complications in open versus robotic cystectomy. European Urology. 2010 Feb; 57(2): 274-281.
  8. Kauffman EC, Ng CK, Lee MM, Otto BJ, Portnoff A, Wang GJ, Scherr DS. Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.  British Journal of Urology International, 2010 Feb: 105(4): 520-527.          
  9. Kauffman EC, Ng CK, Lee MM, Otto BJ, Wang GJ, Scherr DS.  Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy. British Journal of Urology International. 2011 Feb; 107(4): 628-35.
  10. Kauffman EC, Kim HH, Tanrikut C, Goldstein M. Microsurgical spermatocelectomy: technique and outcomes of a novel surgical approach. Journal of Urology. 2011 Jan; 185(1): 238-42. 
  11. Osterberg EC, Kauffman EC, Kang HW, Koullick E, Choi BB.  Optimal laser fiber rotational movement during photoselective vaporization of the prostate in a bovine ex-vivo animal model.  Journal of Endourology. 2011 Jul;25(7):1209-15.
  12. Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ, Mongan NP.  Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Molecular Carcinogenesis. 2011 Dec; 50(12): 931-944.
  13. Kauffman EC, Liu H, Schwartz MJ, Scherr DS.  Toll-like receptor 7 agonist therapy enhances intratumoral lymphocytic infiltration, cytokine production and cancer cell death in a syngeneic renal cell cancer mouse model.  Journal of Oncology.  2012 Feb; 103298.
  14. Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ.  .Estrogen receptor-β expression and pharmacologic targeting in bladder cancer.  Oncology Reports.  2013 Jul 30.
  15. Al-Daghmin A, English S, Kauffman EC, Din R, Khan A, Syed JR, Sztorc J, Mehedint D, Sharif M, Shi Y,            Wilding G, Guru KA. External Validation of Preoperative and Postoperative Nomograms for Prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.  BJU Int. 2014 Aug;114(2):253-60.
  16. Al-Daghmin A, Kauffman EC, Shi Y, Badani K, Balbay MD, Canda E, Dasgupta P, Ghavamian R, Grubb R 3rd, Hemal A, Kaouk J, Kibel AS, Maatman T, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi R, Redorta JP, Rha KH, Richstone L, Schanne F, Scherr DS, Siemer S, Stöckle M, Wallen EM, Weizer A, Wiklund P, Wilson T, Wilding G, Woods M, Guru KA. Efficacy of robot-assisted radical cystectomy in advanced bladder cancer: results from the international radical cystectomy consortium (IRCC). BJU Int. 2013 Nov 13. BJU Int. 2014 Jul;114(1):98-103.
  17. Kauffman EC, Ricketts CJ, Rais-Bahrami, Yang Y, Merino MJ, Bottaro DP, Srinivasan R and Linehan WM. Molecular genetics and cellular characteristics of TFE3 and TFEB translocation renal cell carcinomas. Nat Rev Urol. 2014 Aug;11(8):465-75.
  18. Hanzly M, Fredrick A, Creighton T, Attwood K, Mehedint D, Kauffman EC, Kim HL, Schwaab T. Learning Curves for Robotic-Assisted and Laparoscopic Partial Nephrectomy. J Endourol. 2014 Aug 11. (Epub ahead of print)

Book Chapters

  1. Kauffman, EC, Ng, CK, Rinker-Schaeffer, CW. “Murine Models of Prostate Cancer” in A. Tewari (Ed.), Prostate Cancer: A Comprehensive Perspective. New York: Springer.  January 2013.
  2. Ng, CK, Kauffman, EC, Jadvar, H. “Molecular Imaging in Prostate Cancer Diagnostics”  in A. Tewari (Ed.), Prostate Cancer: A Comprehensive Perspective. New York: Springer. January 2013.
  3. Kauffman, EC, Pili, R., “Cancer of the Kidney” Abeloffs Clinical Oncology 5th Edition.  In Revision

Select Abstracts/Presentations

  1. Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN, Trepel JB, Pinto PA. Lack of impact of robotic-assisted radical prostatectomy on circulating tumor cell levels in patients with clinically localized prostate cancer. Annual Meeting of the American Urological Association. San Diego, CA. May, 2013.
  2. Kauffman EC, Foster BA, Greenberg NM.  The effect of androgen withdrawal on the expression of the fibroblast-growth-factor axis in prostate cancer cell lines. Southern California Conference on Undergraduate Research.  California State University, CA, October 11, 1997.
  3. Kauffman, EC; Chekmareva, MA; Koons, A; Rinker-Schaeffer, CW.   Functional characterization of the prostate cancer metastasis suppressor gene, KAI1.  Annual Meeting of Howard Hughes Medical Student Fellows. Bethesda, MD, May 13-15, 2002
  4. Kauffman, EC; Chekmareva, MA; Koons, A; Rinker-Schaeffer, CW; Vander Griend, D.   Functional characterization of the prostate cancer metastasis suppressor gene, KAI1.  Biannual Clinical Cancer Metastasis Symposium. Chicago, IL, September 20-22, 2002.
  5. Kauffman, EC. Protein expression of the KAI1 metastasis suppressor gene in renal cell carcinoma and oncocytoma.  Ferdinand C. Valentine Residents’ Essay Contest, New York Section of the American Urological Association.  New York, NY, March 14, 2007.
  6. Kauffman, EC, Barocas, DA, Chen, YT, Yang, XJ, Scherr, DS, Tu, JJ.  KAI1 is a novel marker for chromophobe renal cell carcinoma. Annual meeting of the American Urological Association. Orlando, FL, May 18, 2008
  7. Kauffman, EC, Ng, CK, Wang, GJ, Wysock, JS, Barocas, DA, Raman, JD, Scherr, DS. Experience with robotic-assisted laparoscopic radical cystectomy: peri-operative and short-term oncologic outcomes. Annual meeting of the American Urological Association. Orlando, FL, May 19, 2008.
  8. Kauffman, EC, Ng, CK, Lee, MM, Otto, B, Wang, GJ, Scherr, DS. Comparison of oncologic outcomes for robotic-assisted and open cystectomy in patients with invasive bladder cancer. Annual Meeting of the Society of Urologic Oncology, Bethesda, MD, December 6, 2008. 
  9. Kauffman, EC, Ng, CK, Lee, MM, Otto, B, Wang, GJ, Scherr, DS. A critical analysis of complications after robotic radical cystectomy.  Annual Meeting of the Society of Urologic Oncology, Bethesda, MD, December 6, 2008.
  10. Kauffman, EC, Liu, H, Schwartz, M, Lee, MM, Scherr, DS. Imidazoquinoline drug therapy increases lymphocytic infiltration/activation and induces cancer cell death in primary tumors of a renal cell cancer mouse model.  Annual Meeting of the Society of Urologic Oncology, Bethesda, MD, December 6, 2008.
  11. Kauffman, EC. Expression of BCG-Receptors, Toll-Like Receptors 2 and 4, in Human Bladder Cancer.  Ferdinand C. Valentine Residents’ Essay Contest, New York Section of the American Urological Association. New York, NY, March 25, 2009
  12. Kauffman, EC, Kang, W, Choi BB. Identification of optimal laser-fiber movement for photo-selective vaporization of the prostate in an ex vivo animal model. Engineering and Urology Society Annual Meeting. Chicago, IL. April 25, 2009
  13. Kauffman, EC, Ng, CK, Lee, MM, Otto, B, Wang GJ, Scherr DS.  Early oncologic outcomes for robotic-assisted radical cystectomy in urothelial carcinoma patients. Annual Meeting of the Society of Urologic Oncology, Bethesda, MD, December 4, 2009.
  14. Kauffman, EC. Expression and function of sex-steroid hormone receptors and their co-activators in human bladder cancer. Ferdinand C. Valentine Residents’ Essay Contest, New York Section of the American Urological Association. New York, NY, April 14, 2010
  15. Kauffman, EC, D’Alfonso, T, Robinson, BD, Lee, MM, Lu, H, Scherr, DS.. Expression of Bacillus Calmette Guerin receptors, TLR2 and TLR4, in bladder cancer cells and correlation with clinical response. Annual meeting of the American Urological Association. San Francisco, CA, May 30, 2010.
  16. Kauffman, EC, Ng, CK, Lee, MM, Otto, B, Wang, GJ, Scherr, DS.. Risk factors for venous thromboembolic events after radical cystectomy in cancer patients. Annual meeting of the American Urological Association. San Francisco, CA, June 2, 2010.
  17. Kauffman, EC, Shuch, B, Lee, MJ, Alarcon, SV, Srinivasan, R, Linehan, WM, Trepel, JB, Bratslavsky, G.  Detection of circulating tumor cells in renal cell carcinoma patients with identification of candidate cell-surface protein markers: analysis of the published literature. Annual Meeting of the Society of Urologic Oncology. Bethesda, MD, December 9, 2010.
  18. Kauffman, EC, Lee, MJ, Alarcon, SV, Williams H, Lee, S, Linehan, WM, Pinto, P, Bratslavsky, G, Trepel, JB.  Multiparameter flow cytometric analysis of renal cell cancer tumor microenvironment. Annual meeting of the American Urological Association. Washington, DC, May 15, 2011.
  19. Kauffman EC, Lee MJ, Alarcon SV, Lee SM, Linehan WM, Trepel JB, Pinto P.  Does Intraoperative Shedding of Prostate Cancer Circulating Tumor Cells Occur During Robotic Prostatectomy?  Annual Meeting of the Society of Urologic Oncology. Washington DC, December 2011.
  20. Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ.  Estrogen receptor-beta expression and pharmacologic targeting in bladder cancer.  Annual Meeting of the American Urological Association. Atlanta, GA.  May, 2012.
  21. Kauffman EC, Gupta G, Yang Y, Raffesberger K, Cecchi F, Bottaro D, Linehan WM, Srinivasan R.Characterization of the Akt-mTOR pathway in TFE3-fusion renal cell cancer and implications for targeted therapy. Annual Meeting of the American Urological Association. Atlanta, GA. May, 2012.
  22. Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN, Trepel JB, Pinto PA. Lack of impact of robotic-assisted radical prostatectomy on circulating tumor cell levels in patients with clinically localized prostate cancer. Annual Meeting of the American Urological Association. San Diego, CA. May, 2013.
  23. Kauffman EC, Rais-Bahrami S, Gupta G, Nix JW, Yang Y, Linehan WM, Srinivasan R. Preclinical Efficacy of AZD8055, a Dual mTORC1/2 Inhibitor, in RCC Harboring TFE3 Gene Fusions. Annual Meeting of the American Urological Association. San Diego, CA. May, 2013.
  24. Kauffman EC. Active surveillance as a first-line option for kidney cancer:  Does your patient really need that small kidney tumor removed? Bradford Regional Medical center Grand Rounds. Bradford, PA. March, 2014.

 

Eric C. Kauffman

Assistant Professor

 

  • :(716) 845-8498
    Fax No.:(716) 845-3300

  • DEPARTMENTDepartments of Urology and Cancer
    Genetics
    Roswell Park Cancer Institute
  • COUNTRY USA